Michael Kasper

14.4k total citations · 2 hit papers
249 papers, 10.7k citations indexed

About

Michael Kasper is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cell Biology. According to data from OpenAlex, Michael Kasper has authored 249 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 77 papers in Pulmonary and Respiratory Medicine and 71 papers in Cell Biology. Recurrent topics in Michael Kasper's work include Neonatal Respiratory Health Research (38 papers), Caveolin-1 and cellular processes (32 papers) and Skin and Cellular Biology Research (27 papers). Michael Kasper is often cited by papers focused on Neonatal Respiratory Health Research (38 papers), Caveolin-1 and cellular processes (32 papers) and Skin and Cellular Biology Research (27 papers). Michael Kasper collaborates with scholars based in Germany, United States and United Kingdom. Michael Kasper's co-authors include P Stosiek, Kathrin Barth, Uwe Karsten, Marek Dráb, Angelika Bierhaus, Teymuras V. Kurzchalia, Paul Verkade, Norbert F. Voelkel, Friedrich C. Luft and Carsten Lindschau and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Michael Kasper

240 papers receiving 10.4k citations

Hit Papers

Loss of Caveolae, Vascular Dysfunction, and Pulmonary Def... 1996 2026 2006 2016 2001 1996 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Kasper Germany 51 3.6k 3.2k 2.2k 1.3k 1.2k 249 10.7k
Peter Boor Germany 62 5.2k 1.4× 1.9k 0.6× 699 0.3× 414 0.3× 1.8k 1.6× 449 14.7k
Matthias Kretzler United States 85 8.3k 2.3× 2.2k 0.7× 958 0.4× 873 0.7× 2.2k 1.9× 340 22.3k
Roel Goldschmeding Netherlands 65 5.4k 1.5× 2.6k 0.8× 546 0.2× 283 0.2× 1.3k 1.1× 259 12.3k
Clemens D. Cohen Germany 57 3.7k 1.0× 1.0k 0.3× 541 0.2× 432 0.3× 1.1k 1.0× 146 9.8k
Navneet Narula United States 47 3.0k 0.8× 2.5k 0.8× 601 0.3× 231 0.2× 1.8k 1.5× 198 9.6k
Sean M. Davidson United Kingdom 68 6.9k 1.9× 1.3k 0.4× 479 0.2× 296 0.2× 2.0k 1.7× 219 13.9k
Geert W. Schmid‐Schönbein United States 53 1.9k 0.5× 1.2k 0.4× 940 0.4× 141 0.1× 1.4k 1.2× 177 8.9k
Cong‐Yi Wang China 53 2.7k 0.8× 877 0.3× 425 0.2× 444 0.3× 1.0k 0.9× 231 8.1k
Norbert Gretz Germany 54 6.1k 1.7× 916 0.3× 632 0.3× 183 0.1× 960 0.8× 246 11.8k
Yukio Yuzawa Japan 44 1.7k 0.5× 794 0.3× 455 0.2× 257 0.2× 1.1k 0.9× 199 6.7k

Countries citing papers authored by Michael Kasper

Since Specialization
Citations

This map shows the geographic impact of Michael Kasper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kasper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kasper more than expected).

Fields of papers citing papers by Michael Kasper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kasper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kasper. The network helps show where Michael Kasper may publish in the future.

Co-authorship network of co-authors of Michael Kasper

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kasper. A scholar is included among the top collaborators of Michael Kasper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kasper. Michael Kasper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leventouri, Theodora, et al.. (2023). A novel Monte Carlo (MC) dose model for small MLC fields of the cyberknife® M6TM radiosurgery system using the EGSnrc. Journal of Applied Clinical Medical Physics. 24(4). e13880–e13880. 1 indexed citations
2.
Devlin, Phillip M., Shervin M. Shirvani, Christopher A. Barker, et al.. (2016). Skin surface brachytherapy: A survey of contemporary practice patterns. Brachytherapy. 16(1). 223–229. 36 indexed citations
3.
Ouhib, Zoubir, Michael Kasper, José Pérez‐Calatayud, et al.. (2015). Aspects of dosimetry and clinical practice of skin brachytherapy: The American Brachytherapy Society working group report. Brachytherapy. 14(6). 840–858. 106 indexed citations
4.
Augstein, Antje, et al.. (2014). Effect of P2X7 Receptor Knockout on AQP-5 Expression of Type I Alveolar Epithelial Cells. PLoS ONE. 9(6). e100282–e100282. 15 indexed citations
5.
Rodríguez, Silvia, R. Botella, Antonio Ballesta, et al.. (2014). Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes. Journal of Contemporary Brachytherapy. 2(2). 167–172. 63 indexed citations
6.
Keller, U, Michael Kasper, Angelika Bierhaus, et al.. (2013). RAGE-mediated interstitial fibrosis in neonatal obstructive nephropathy is independent of NF-κB activation. Kidney International. 84(5). 911–919. 31 indexed citations
7.
Shivshankar, Pooja, et al.. (2012). Caveolin-1 Deficiency Protects from Pulmonary Fibrosis by Modulating Epithelial Cell Senescence in Mice. American Journal of Respiratory Cell and Molecular Biology. 47(1). 28–36. 74 indexed citations
8.
Bogaard, Harm Jan, Shiro Mizuno, Stefano Toldo, et al.. (2011). Suppression of Histone Deacetylases Worsens Right Ventricular Dysfunction after Pulmonary Artery Banding in Rats. American Journal of Respiratory and Critical Care Medicine. 183(10). 1402–1410. 133 indexed citations
9.
Spieth, Peter, Alysson R. Carvalho, Andreas Güldner, et al.. (2011). Pressure support improves oxygenation and lung protection compared to pressure-controlled ventilation and is further improved by random variation of pressure support*. Critical Care Medicine. 39(4). 746–755. 60 indexed citations
10.
Bogaard, Harm Jan, Ramesh Natarajan, Shiro Mizuno, et al.. (2010). Adrenergic Receptor Blockade Reverses Right Heart Remodeling and Dysfunction in Pulmonary Hypertensive Rats. American Journal of Respiratory and Critical Care Medicine. 182(5). 652–660. 215 indexed citations
11.
Yildirim, Ali Önder, Gerrit John, Bernd Müller, et al.. (2009). Palifermin Induces Alveolar Maintenance Programs in Emphysematous Mice. American Journal of Respiratory and Critical Care Medicine. 181(7). 705–717. 48 indexed citations
12.
Spieth, Peter, Alysson R. Carvalho, Paolo Pelosi, et al.. (2009). Variable Tidal Volumes Improve Lung Protective Ventilation Strategies in Experimental Lung Injury. American Journal of Respiratory and Critical Care Medicine. 179(8). 684–693. 120 indexed citations
13.
Pradeep, Roshini, Carlyne D. Cool, Judy King, et al.. (2008). The Cancer Paradigm of Severe Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 178(6). 558–564. 194 indexed citations
14.
Jorde, Ulrich P., Timothy J. Vittorio, Michael Kasper, et al.. (2007). Chronotropic Incompetence, Beta-Blockers, and Functional Capacity in Advanced Congestive Heart Failure: Time to Pace?. European Journal of Heart Failure. 10(1). 96–101. 61 indexed citations
15.
Voelkel, Norbert F., Carlyne D. Cool, Mark W. Geraci, et al.. (2002). Janus face of vascular endothelial growth factor: The obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension. Critical Care Medicine. 30(Supplement). S251–S256. 75 indexed citations
16.
Fehrenbach, Heinz, Ralf Weiskirchen, Michael Kasper, & Axel M. Gressner. (2001). Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts. Hepatology. 34(5). 943–952. 135 indexed citations
17.
Roehlecke, Cora, et al.. (2000). Resistance of L132 lung cell clusters to glyoxal-induced apoptosis. Histochemistry and Cell Biology. 114(4). 283–292. 11 indexed citations
18.
Fehrenbach, Heinz, Michael Kasper, Thomas Tschernig, et al.. (1999). Keratinocyte growth factor-induced hyperplasia of rat alveolar type II cells in vivo is resolved by differentiation into type I cells and by apoptosis. European Respiratory Journal. 14(3). 534–534. 84 indexed citations
19.
Kasper, Michael, et al.. (1992). Cytokeratin pattern of clinically intact and pathologically changed oral mucosa. International Journal of Oral and Maxillofacial Surgery. 21(1). 35–39. 26 indexed citations
20.
Stosiek, P, Michael Kasper, & Uwe Karsten. (1990). Expression of cytokeratins 8 and 18 in human Sertoli cells of immature and atrophic seminiferous tubules*. Differentiation. 43(1). 66–70. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026